Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of William C. Powell
Introduction
William C. Powell is a notable inventor based in Renton, WA (US). He has made significant contributions to the field of medical technology, particularly in cancer treatment. His work focuses on the interactions between epidermal growth factor receptor (EGFR) and regulatory proteins, which has implications for predicting patient responses to therapies.
Latest Patents
William C. Powell holds a patent for "Methods of predicting response of a neoplasm to an EGFR inhibitor and detecting interactions between EGFR and an EGFR regulatory protein." This patent discloses antigen-binding molecules, such as antibodies, that specifically recognize a portion of the EGFR C-terminal regulatory domain. These molecules are crucial for understanding the regulated state of EGFR and predicting the response of cancer patients to EGFR inhibitor therapies. His innovative approach aims to enhance the treatment strategies for neoplasms, making it a valuable asset in oncology.
Career Highlights
Powell is associated with Ventana Medical Systems, Inc., where he applies his expertise in developing advanced diagnostic tools. His work has contributed to the understanding of cancer biology and the development of targeted therapies. With a focus on improving patient outcomes, Powell's research is at the forefront of medical innovation.
Collaborations
Some of his notable coworkers include Linda Willoughby Kivi and Patrick C. Roche. Their collaborative efforts have furthered the research and development of effective cancer treatments.
Conclusion
William C. Powell's contributions to the field of cancer research and treatment exemplify the impact of innovative thinking in medicine. His patent and work at Ventana Medical Systems, Inc. highlight the importance of understanding molecular interactions in developing effective therapies.